Avid Bioservices Inc (NASDAQ:CDMO)

3.34
Delayed Data
As of Jun 20
 -0.14 / -4.02%
Today’s Change
2.24
Today|||52-Week Range
5.78
-13.92%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$201.1M

Company Description

Avid Bioservices, Inc. is a biopharmaceutical company that engages in the provision of monoclonal antibody therapeutics. It operates through Peregrine and Avid segments. The Peregrine segment refers to research and development of monoclonal antibodies for the treatment and diagnosis of cancer. The Avid segment provides contract management services for peregrine and third-party customers on a fee-for-services basis. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.

Contact Information

Avid Bioservices, Inc.
2642 Michelle Drive
Tustin California 92780-7017
P:(714) 508-6100
Investor Relations:

Employees

Shareholders

Mutual fund holders5.35%
Other institutional32.39%
Individual stakeholders0.35%

Top Executives

Roger J. LiasPresident, Chief Executive Officer & Director
Mark R. ZiebellSecretary, Vice President & General Counsel
Shelley P. M. FusseyVice President-Intellectual Property
Kerstin B. MenanderHead-Medical Oncology